Work for Protagenic Therapeutics, Inc.?

Claim Your Profile

Protagenic Therapeutics, Inc. Logo Image

Protagenic Therapeutics, Inc.

Protagenic Therapeutics, Inc. has reached its limit for report views.

Please check back to see if Protagenic Therapeutics, Inc. has upgraded their profile page to allow their financial information to be viewed. In the meantime, here are a few annual reports from similar companies.

About Protagenic Therapeutics, Inc.

1-10 Employees
Based in New York, New York

Protagenic Therapeutics, Inc. (OTCQB: PTIX) is a pre-clinical biopharmaceutical company endeavoring to develop first-in-class neuro-active peptides into human therapeutics to treat anxiety, treatment-resistant depression, and other disorders.

Ticker:
PTIX
Exchange:
OTC (See More OTC Companies)
Industry:
Networking & Communication Devices (See More Networking & Communication Devices Companies)
Sector:
Technology (See More Technology Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol